Latest Schemes Of Arrangement News

Mayne Pharma updates investors on the extended FIRB approval deadline and potential financing hurdles in its proposed acquisition by Cosette Pharmaceuticals.

Infomedia Ltd shareholders have overwhelmingly approved a scheme of arrangement for acquisition by TPG Capital, valuing the company at approximately AUD 651 million. The deal, supported by the board and an independent expert, is set to complete by early December 2025.

Aurumin Limited shareholders and optionholders have overwhelmingly approved a scheme of arrangement for Brightstar Resources to acquire 100% of Aurumin shares, setting the stage for imminent court approval and market suspension.

Warriedar Resources Limited’s shares will be suspended from trading following court approval of Capricorn Metals’ acquisition scheme, marking a significant consolidation in Western Australia’s gold mining sector.

Aurumin Limited shareholders and optionholders convened on 14 November 2025 to vote on a scheme of arrangement for Brightstar Resources to acquire 100% of Aurumin, with strong proxy support signaling broad approval ahead of final court sanction.

The Takeovers Panel has intervened in the Mayne Pharma and Cosette Pharmaceuticals scheme, issuing interim orders that extend the deal deadline and restrict termination rights to maintain the status quo.

The Takeovers Panel has issued interim orders extending the deadline for Mayne Pharma's takeover scheme with Cosette Pharmaceuticals, preventing termination without consent and maintaining the status quo.

Infomedia Limited has secured Foreign Investment Review Board approval for its proposed acquisition by TPG Capital-backed McQueen BidCo, marking a key regulatory milestone. The Infomedia Board continues to recommend shareholder support ahead of upcoming votes.

Capricorn Metals Ltd has officially completed its acquisition of Warriedar Resources Limited through a court-approved scheme of arrangement, marking a significant consolidation in the gold mining sector.

The Foreign Investment Review Board has extended its deadline for approving Mayne Pharma's acquisition by Cosette Pharmaceuticals, maintaining the current transaction timetable for now.

The Australian Competition and Consumer Commission has given the green light to Southern Cross Media’s proposed acquisition of Seven West Media, marking a significant regulatory milestone in the evolving Australian media landscape.

AUB Group delivered a robust FY25 with a 17.1% rise in underlying net profit and a 15% dividend increase, while navigating a $45 per share acquisition proposal from an EQT-CVC consortium.